145 related articles for article (PubMed ID: 7534075)
1. Autocatalytic inactivation of lysosomal cathepsins is associated with inhibition of protein breakdown by insulin-like growth factor-1 (IGF-1) in myotubes.
Tsujinaka T; Ebisui C; Fujita J; Morimoto T; Ogawa A; Ishidoh K; Kominami E; Yano M; Shiozaki H; Monden M
Biochem Biophys Res Commun; 1995 Mar; 208(1):353-9. PubMed ID: 7534075
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolic acidosis on the insulin-like growth factor-I system and cathepsins B and L gene expression in the kidney.
Fawcett J; Hsu FW; Tsao T; Rabkin R
J Lab Clin Med; 2000 Dec; 136(6):468-75. PubMed ID: 11128748
[TBL] [Abstract][Full Text] [Related]
4. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.
Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K
Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136
[TBL] [Abstract][Full Text] [Related]
5. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
Afonso S; Romagnano L; Babiarz B
Development; 1997 Sep; 124(17):3415-25. PubMed ID: 9310336
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of cathepsins B and L expression in the monkey hippocampus after transient ischemia.
Kohda Y; Yamashima T; Sakuda K; Yamashita J; Ueno T; Kominami E; Yoshioka T
Biochem Biophys Res Commun; 1996 Nov; 228(2):616-22. PubMed ID: 8920959
[TBL] [Abstract][Full Text] [Related]
7. Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways.
Waguri S; Sato N; Watanabe T; Ishidoh K; Kominami E; Sato K; Uchiyama Y
Eur J Cell Biol; 1995 Aug; 67(4):308-18. PubMed ID: 8521870
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin L plays an important role in the lysosomal degradation of L-lactate dehydrogenase.
Ohshita T; Hiroi Y
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2254-61. PubMed ID: 16960372
[TBL] [Abstract][Full Text] [Related]
9. Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation.
Tanabe H; Kumagai N; Tsukahara T; Ishiura S; Kominami E; Nishina H; Sugita H
Biochim Biophys Acta; 1991 Sep; 1094(3):281-7. PubMed ID: 1911879
[TBL] [Abstract][Full Text] [Related]
10. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
Lah TT; Hawley M; Rock KL; Goldberg AL
FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins.
Turk B; Bieth JG; Björk I; Dolenc I; Turk D; Cimerman N; Kos J; Colic A; Stoka V; Turk V
Biol Chem Hoppe Seyler; 1995 Apr; 376(4):225-30. PubMed ID: 7626231
[TBL] [Abstract][Full Text] [Related]
12. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
13. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
[TBL] [Abstract][Full Text] [Related]
14. Degradation of serum albumin by rat liver and kidney lysosomes.
Ohshita T; Hiroi Y
J Nutr Sci Vitaminol (Tokyo); 1998 Oct; 44(5):641-53. PubMed ID: 9919484
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
Gerber A; Wille A; Welte T; Ansorge S; Bühling F
J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
[TBL] [Abstract][Full Text] [Related]
17. Pathways of protein degradation in L6 myotubes.
Fernandez C; Sainz RD
Proc Soc Exp Biol Med; 1997 Mar; 214(3):242-7. PubMed ID: 9083257
[TBL] [Abstract][Full Text] [Related]
18. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
Gerber A; Welte T; Ansorge S; Bühling F
Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
[TBL] [Abstract][Full Text] [Related]
20. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
